Cheng Y, Teng Z, Zhang Y, Jin B, et al. Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II study. BMC Cancer 2024;24:1082.
PMID: 39223545